TLDR
- Rocket Lab SVP Arjun Kampani sold 88,000 RKLB shares on June 18 at $107.98, totaling ~$9.5 million.
- The sale reduced Kampani’s stake by 24.95%; he still holds 264,705 shares worth ~$28.6 million.
- RKLB traded down to $107.24 on heavy volume — nearly triple its average daily volume.
- Rocket Lab posted 63.4% year-over-year revenue growth in Q1 and beat analyst estimates.
- The stock is set to join the Nasdaq-100 on June 22, which could drive passive fund buying.
Rocket Lab (RKLB) SVP and General Counsel Arjun Kampani sold 88,000 shares on June 18 at an average price of $107.98, pulling in approximately $9.5 million from the transaction.
Following the sale, Kampani still directly owns 264,705 shares, valued at roughly $28.6 million. The transaction represents a 24.95% reduction in his personal stake.
This wasn’t a one-off move. Kampani has been selling steadily — he offloaded 28,668 shares on May 26 at $142.57, then 70,000 on May 27 at $145.13, and another 23,804 on May 28 at $147.43.
Over the past year, he has sold a total of 342,714 shares. There have been zero insider purchases recorded during that same period, and 43 insider sales in total across the company.
RKLB stock fell $0.74 on the day, closing at $107.24. Volume hit 70.2 million shares — nearly three times the average daily volume of 24.8 million.
Stock Still Well Above Long-Term Average
Despite the pullback, RKLB is trading well above its 200-day moving average of $82.68 and its 50-day average of $104.00. The stock’s 52-week range runs from a low of $27.84 to a high of $151.00.
The market cap stands at $62.07 billion. The price-to-earnings ratio sits at -335.12, reflecting the company is not yet profitable. The beta is 2.49, meaning the stock moves sharply relative to the broader market.
Analysts put the average consensus price target at $102.76, with a “Moderate Buy” rating. Price targets range from $105 (KGI Securities, neutral) to $150 (New Street Research, buy). Stifel Nicolaus has a $132 target; KeyCorp recently upgraded the stock to overweight with a $135 target.
Strong Fundamentals, Valuation Questions Remain
In its most recent earnings report on May 7, Rocket Lab posted revenue of $200.35 million, beating analyst estimates of $189.65 million by roughly $10.7 million.
Revenue was up 63.4% year-over-year. EPS came in at -$0.07, matching consensus. The company carries a $2.2 billion backlog.
Rocket Lab also recently cleared a key Space Development Agency review, strengthening its defense program credentials.
Starting June 22, RKLB will be added to the Nasdaq-100 index. That inclusion typically triggers passive buying from index funds and ETFs that track the index.
Institutional ownership currently sits at 71.78%. Vanguard holds 47.4 million shares, Baillie Gifford owns 17.9 million, and Capital World Investors holds 16.2 million.
GuruFocus estimates the stock’s intrinsic value at $26.42, putting its price-to-GF-Value ratio at 4.09 — a level it flags as overvalued.
Sell-side analysts project full-year EPS of -$0.29 for the current fiscal year.
🚨 Our JUNE Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for June, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!







